3,4-Methylene-dioxymethamphetamine
(MDMA : Ecstasy)

REFERENCES
and further reading

• 2009
• 2008/PTSD treatment
• 2C-B ('Nexus', 'Venus', 'Bromo', 'Eros')
• 2C-D
• 2C-E
• 2C-I
• 2C-T-2
• 2C-T-7 ('Blue Mystic', 'Lucky 7')
• 2C-T-7 (Alexander Shulgin interview)
• 2-DG
• 4-MTA ('Flatliner')
• 5-HT1a receptor
• 5-HT1a receptor density/spirituality
• 5-HT1b
• 5-HT2
• 5-HT2a
• 5-HT2b
• 5-HT2c
• 5-HT3
• 15N isotopic analysis
• Abstinence
• ACEA 1021
• Accidental ecstasy?
• Acid House
• Acetylcholine
• Acetylcholine/prefrontal
• Acetylcholinesterase
• Acetyl-l-carnitine/neuroprotection
• Acute effects
• Adult neurogenesis
• After-effects
• Aggression/MDMA
• Alcohol/CPP
• Alcohol/MDMA
• Aldosterone
• Alexander Shulgin
• Allergic reaction?
• Alpha(2)-adrenoceptors
• Alpha-lipoic acid
• Amphetamines.com
• Anger/aggression
• Animal data
• Anticataleptic?
• Antihistamines
• Anti-Parkinsonian effect?
• Antiretrovirals
• Anxiety disorders/treatment
• Anxiety/mice
• Anxiety/rats
• Anxiolytic/anxiogenic
• Appetite
• Arginine-vasopressin
• Ascorbic acid
• Aspirin?
• Aspirin/PHS
  
• Atrial-fibrillation
• Attention
• Australia
• Baboons
• Baby rats
• Baclofen/body temperature
• Behavioral pharmacology
• Behavioral sensitization
• Behavioral toxicity?
• Binge dosing
• Bioenergetics
• Body-clock
• Body temperature
• Brain activity
• Brain cells
• Brain damage?
• Brazil 2009
• Brazilian Ecstasy
• British experience
• Bruxism ('jaw-clenching')
• Buying research chemicals/designer drugs
• BZP (benzylpiperazine)
• C-fos
• Ca2(+) toxicity?
• Caffeine + MDMA
• Candyflipping
• CB(1)cannabinoid receptors/MDMA
• Cannabinoid neuroprotection
• Cannabinoids/MDMA use
• Cannabis confounds
• Cannabis/memory
• Cardiotoxicity
• Cardiovascular effects
• Carvedilol/hyperthermia reversal
• Charles Grob
• 'Chemi-kids'
• Chronic MDMA use/effects
• Chronic intravenous MDMA
• Citalopram
• Circadian clock effects
• Claudio Naranjo
• Clinical therapy
• Clozapine/hyperthermia reversal
• 'Club drugs'
• Cocaine/MDMA
• Cocaine sensitisation
• Cognition
• Cognitive flexibility
• Confounding problem/polydrug use
• Controversies
• Counter-transport model
• Cortex/gene expression
• Crowding
• CYP2D6
• Daily MDMA
• Dances/raves
• 'Date rape'
• Depression
• Depression/longitudinal analysis
• Designer drugs
• Designer drugs/Ecstasy
• DHEA
• Discriminative stimulus effects
• Dyskinesia suppression
• DOM (from PiHKAL)
• Dopamine
• Dopamine D1 and D2 receptors
• Dopamine function
• Dopamine/MAO-b
• Dopamine neurons
• Dopamine/neurotoxicity
• Dopamine/serotonin
• Dopamine/serotonin
• Dopamine/5-HT2 agonists
• Dorsal raphe neurons
• Driving
• Drug sensitization
• Drug testing
• Drugs/music/ideology
• Drugs/psychotherapy
• Dutch Ecstasy
• Ecstasy campaign
• Ecstasy/cannabis use
• Ecstasy culture
• Ecstasy/cyberspace
• Ecstasy and honesty
• Ecstasy/methamphetamine users
• Ecstasy or Speed?
• Ecstasy slang
  
• Ecstasy: the complete guide
• Ecstasy use/mood disorders
• Ecstatic variety
  
• Empathy/aggression
• Enantiomers/MDMA
• Endocannabinoids/MDMA
• Energy dysregulation
• Enkephalin
• Entactogens
• Entactogens/MDMA/MBDB
• Entactogens/MDMA/MDE
• 'Epidemiology'/MDMA
• ERK activation
• Estrogen
• Ethanol/MDMA
• Euphoria
• Executive function
• Exercise/MDMA reward
• Ex-users
• Fake E
• False positives/immunoassay screening
• Fasciculus retroflexus
• Fatalities
• Fear/facial expressions
• Fenfluramine
• Fetal exposure
• Fluoxetine/MDMA
• fMRI
• Free radical damage
• GABA
• GABA/serotonin/dopamine
• 'Generation Ecstasy'
• Gender
• Genetic polymorphism
• Germany
• GBR-12909
• Global Ecstasy
• Glutamate synapses
• Glutathione depletion
• Glutathione conjugates
• Hair-testing
• Haloperidol/MDMA
• Hangover
• Harm reduction
• Heart/5-HT2b
• Heavy use
• Hepatotoxicity
• HHMA
• HHMA/monoamines
• Hippocampus
• History of MDMA
• HIV/club-drugs
• Homologues
• HPA/stress/dopamine
• Human neurotoxicity
• Hyponatraemia
• Hyperdopaminergic innervation
• Hyperkalemia
• Hyperpyrexia
• Hyperthermia
• Hyperthermia/environment
• Hyperthermia/HPT axis
• Ibiza
• Imidazoline receptors
• Immune response
• Immunosuppressant?
  
• Immunohistochemical detection
• Impulsivity
• Impurities
• Impurity testing
• Information sources
• Intracerebral microinjection
• Intravenous MDMA
• Isomers/reinforcing potency
• Japanese Ecstasy
• Julie Holland MDMA interview
  
• Ketanserin
• Kidney damage
• L-cysteine
• L-deprenyl
• L-dopa
• 'Legal x'/ TFMPP + BZ
• L-tryptophan
• L-tyrosine/toxicity
• Liver
• Locomotor effects
• Locomotion/dopamine
• Loneliness
• Long-term effects
• Lymphocytes
  
• Malignant hyperthermia
• MAO-b/MDMA
• MAO-b/toxicity
• MAOI interaction
• MBDB/Eden (from PiHKAL)
• MBDB
• MBDB/mechanisms
• McPP
• MDA (from PiHKAL)
• MDA
• MDA: structure
  
• MDA psychotherapy
• MDE/Eve (from PiHKAL)
• MDE
• MDE/toxicity
• MDE enantiomers
• MDMA/Ecstasy: Merck origin
  
• MDMA/MDE
• MDMA/5-HT receptors
• MDMA/Ecstasy (from PiHKAL)
• MDMA/acute, sub-acute, long-term
• MDMA antagonist(?): nantenine
• MDMA/controversy
• MDMA/MDL-11,939
• MDMA/P450 2D6
• MDMA/cannabis
• MDMA/cognition
• MDMA/dopamine biochemistry
• MDMA/dopamine/serotonin
• MDMA/GABA genes
• MDMA + GHB
• MDMA/glucose
• MDMA/health
• MDMA/immune system
• MDMA/MAO-b
• MDMA/Non-addictive
• MDMA/cannabis/memory
• MDMA/memory/gender
• MDMA/moclobemide
• MDMA/moclobemide risk
• MDMA/music
• MDMA/painkiller
• MDMA/paroxetine (Paxil)
• MDMA/patent
• MDMA/pharmacology
• MDMA/prenatal
• MDMA/repeated exposure
• MDMA/Ricaurte
• MDMA/serotonin neurons
• MDMA/serotonin transporters
• MDMA/sexuality
• MDMA/students
• MDMA/therapeutic use
• MDMA therapy
• MDMA/thermoregulation
• MDMA/toxic metabolites(?)
• MDMA/tryptophan
• MDMA v cocaine
• MDPPP
• Memantine/neuroprotective
• Memory
• Memory/cannabis/MDMA
• Memory deficits/MDMA use
• Men vs women
• Mental disorders
• Merck
• Mephedrone vs MDMA
• Mesolimbic dopamine
• Minoxidil/neuroprotective
• MK-Ultra
• MMDA (from PIHKAL)
• MMDA
• 4-MTA ('flatliner')
• Metabolism
• Metabolites
• Methamphetamine + MDMA
• Methylone
• Methylone/mCPP
• Mice
• Michael Mithoefer/PTSD trial
• Microglia
• Military/PTSD
• Mitochondria
• Monkeys
• Monoamine transporters
• Mood/cognition
• Multidrug use
• Muscle damage/exercise
• Negative experiences
• Neonatal ecstasy
• Nerve terminals
• Neuroadaptation
• Neurocognitive deficits
• Neurocognitive function
• Neuroendocrine
• Neuroimaging
• Neuronal damage
• Neuropharmacology
• Neuropharmacology/neurotoxicity
• Neurotoxicity
• Neurotoxicity: evidence
• Neurotransmitters
• New Zealand
• NIR testing
• Nitric oxide
• Nitric oxide/nNOS
• Nitric oxide synthase/dopamine
• NMDA receptor
• Noise/heart
• Noradrenaline
• Older users
• Opioids/MDMA
• Opioid receptors/MDMA
• Organized crime
• Oxidative stress
• Oxytocin
• Oxytocin release/5-HT(1a) receptors
• Oxytocin release/prosocial effects
• Oxytocin/vasopressin secretion
• Para-chlorophenylalanine
• Parkinson's (Ricaurte)
• Parkinson's/symptomatic relief
• Partying/MDMA
• 'Party drugs'
• PBN
• Personality
• PEA (from PiHKAL)
• Perinatal Ecstasy
• Performance
• Periodontitis
• PET scan
• Pharmacology
• Pharmacokinetics
• Phenylalkylamines
• Phosphatidylinositol
• Pigs
• PiHKAL
• Pill-testing
• P.L.U.R.
• PMA (from PiHKAL)
• Pleasure centres
• PMA
• PMA/anise oil
• PMMA (from PiHKAL)
• PMMA
• Polydrug use
• Polydrug/MDMA users
• Post-hypnotic Ecstasy?
• Post-traumatic Stress Disorder?/MDMA
• Pregnancy
• Preloading and postloading
• Prenatal
• Primates/toxicity
• Prodynorphin
• Prolactin elevation
• Prostaglandin H synthase (PHS)
• Protection
• Protein kinase C
• Prozac
• Psychomotor performance
• Psychostimulants/sensitisation
• Psychotherapy, drug-assisted
• Psychiatric disorders
• Psychosis
• PTSD/metanalysis
• PTSD/MDMA therapy
• PTSD/MDMA pilot trial (2010)
• Purity
• Quinol-thioether conjugates
• Quitting
• Racemic MDMA/cocaine
• Raman spectroscopy E-test
• Rats/mice
• Rats/ecstasy
• Raves
• RAVE/ROAR
  
• Raving/USA
  
• Rat trace amine receptor
• Receptors
• Recreational users/subjective effects
• 'Reefer Madness'
• Repeated doses
• Research chemicals
• Residual effects
• Ricaurte, GA
• Ricaurte's retraction
• Ritanserin
• Safrole
• Screening
• Seizures
• Selegiline
• Selenium
• Serotonin
• Serotonin axons
• Serotonin axonal resprouting
• Serotonin depletion
• Serotonin/dopamine
• Serotonin/GABA interactions
• Serotonin release
• Serotonin-releasers
• Serotonin syndrome?
• Serotonin transporters
• Serotonin/dopamine
• Serotonin/reward
• Serotonin syndrome risk
• Serotonin transporter polymorphism
• Serotonergic toxicity
• SERT alterations/reversibility
• Sex
  
• Sexstasy
• Sexual pleasure/MDMA
• Sigma(1) receptors/MDMA
• Sociability/MDMA exposure
• SPECT/serotonin transporter
• Spirituality
• SSRIs/neuroprotection
• Stereochemistry
• Stereoisomers
• Stereotype threat
• STP (from PiHKAL)
• Stress/d-MDMA
• Striatal changes
• Striatal mRNA expression
• Structure
• Students
• Subarachnoid haemorrage
• Subjective effects
• Suicide attempt
• Sweat testing
• Synaptic vesicles
• Synthesis
• Synthesis byproducts
• Tablet purity
• Taiwan
• TDIQ
• Temperature effects
• Terminally ill/MDMA trial
• TFMPP
• Therapy
• Therapy/method
• Thermogenesis
• Thermoregulation
• Thioether metabolites
• Thioether metabolites/neurotoxic accumulation?
• Tolerance to chronic MDMA use
• Tolerance/cross-tolerance
• Toxicity
• Toxicity: mechanisms
• Toxicity: negative finding
• Toxicity/tau phosphorylation
• Toxic metabolites?
• Tryptophan
• Tryptophan, memory
• Tryptophan hydroxylase
• UCP-3 ('uncoupling protein-3')
• UK deaths
• UK Ecstasy
• Unsafe sex
• Urban youth networks
• Urinary retention
• Urine testing
• Vanoxerine/MDMA
• Vascular action
• Vasoconstriction
• Vasopressin
• Verbal memory
• Vietnam
• Visuospatial memory
• Vitamin C
• Vitamin E
• Water intoxication
• Water supplies/MDMA enrichment
• Women/midweek mood
• Working memory task rules
• XTC
• Yaoto-wang
• Zeff, Leo
• Zinc

    

Suggested additions/updates?
E-mail: dave@bltc.com